EMA Application withdrawn: Kepnetic — Ultragenyx UK Limited

View source ↗

Summary

The EMA withdrew the Kepnetic application for distal myopathies by Ultragenyx UK Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Myopathy

Drugs mentioned

• Kepnetic

Snippet

Status: Application withdrawn. Therapeutic area: Distal Myopathies. MAH: Ultragenyx UK Limited. Decision date: 16/12/2016